Neubase Therapeutics shares owned by Springbok Capital Management
Quarter-by-quarter ownership of Neubase Therapeutics shares owned by Springbok Capital Management
from 13F filings
Historical chart of Springbok Capital Management investment in Neubase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Neubase Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neubase Therapeutics by Springbok Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $7.0k | 16k | 0.45 |
2023-09-30 | $14k | 16k | 0.87 |
2023-06-30 | $29k | 16k | 1.87 |
More positions owned by Springbok Capital Management
View all positions for Springbok Capital Management
Top funds holding Neubase Therapeutics
View all funds holding Neubase Therapeutics